
Benchmark has decided to maintain its Buy rating of Cross Country Healthcare (NASDAQ:CCRN) and lower its price target from $42.00 to $37.00.
Shares of Cross Country Healthcare are trading down 6.22% over the last 24 hours, at $17.33 per share.

Benchmark has decided to maintain its Buy rating of Cross Country Healthcare (NASDAQ:CCRN) and lower its price target from $42.00 to $37.00.
Shares of Cross Country Healthcare are trading down 6.22% over the last 24 hours, at $17.33 per share.